1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 114 results.

Thumbnail for A Real-World Pharmacovigilance Study of Rituximab in Two Heart Failure Phenotypes: Heart Failure With Preserved Ejection Fraction (HFpEF) and Heart Failure With Reduced Ejection Fraction (HFrEF).

ABCL - 735

A Real-World Pharmacovigilance Study of Rituximab in Two Heart Failure Phenotypes: Heart Failure With Preserved Ejection Fraction (HFpEF) and Heart Failure With Reduced Ejection Fraction (HFrEF).

Renusri Ede

Poster Presenter: Renusri Ede

$Thumbnail for Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study$

ABCL - 736

Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study

John M. Burke

Poster Presenter: John M. Burke

Video

ABCL - 738

Temporal Trends in Sepsis-Related Mortality Among Patients With Non-Hodgkin Lymphoma: A 25-Year CDC WONDER Database Analysis

Charan Gandhi Meesala

Poster Presenter: Charan Gandhi Meesala

Thumbnail for A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

ABCL - 753

A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

Jin Jin

Poster Presenter: Jin Jin

Thumbnail for Demographic and Regional Disparities in Respiratory Failure-Related Mortality Among Older Adults With Non-Hodgkin Lymphoma: A 26-Year Nationwide Analysis

ABCL - 755

Demographic and Regional Disparities in Respiratory Failure-Related Mortality Among Older Adults With Non-Hodgkin Lymphoma: A 26-Year Nationwide Analysis

Sai Pavitra Paidimarri

Poster Presenter: Sai Pavitra Paidimarri

ABCL - 820

Genomic Landscape of Primary Thyroid Lymphoma (Ptl): CD79B/MYD88 Alterations and Implications for Polatuzumab-Based Therapy

Mehak Khetarpal

Poster Presenter: Mehak Khetarpal

$Thumbnail for Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)$

ABCL - 853

Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)

Mohamad Cherry

Poster Presenter: Mohamad Cherry

Video

ABCL - 865

Post-CAR-T Relapse in DLBCL: Real-World Salvage Therapy Patterns and Outcomes at a Tertiary Academic Center

Jivtesh Singh

Poster Presenter: Jivtesh Singh

$Thumbnail for Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma$

ABCL - 869

Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma

Francisco Hernandez

Poster Presenter: Francisco Hernandez